Hauptkonkurrenten
Dividendenrendite (Y) Dividendenrendite (Y+1) KGV (Y) Price to Book (Y) EV / Sales (Y) Marktkap. / EBITDA (Y) Marktkap. / EBIT (Y) Kap.($)
- - - - - - - 319’235
0.82%0.92%35.28x4.97x6.67x23.05x27.87x 48.15 Mrd.
1.32%1.41%18.13x1.77x2.05x9.64x12.54x 35.59 Mrd.
0.86%0.98%27.27x3.05x3.37x17.25x21.88x 11.9 Mrd.
0.58%0.6%27.11x3.72x3.99x16.27x22.27x 11.85 Mrd.
3.39%3.74%19.66x3.35x3.44x12.36x14.68x 9.31 Mrd.
5.18%5.55%8.37x1.44x1.97x5.15x6.23x 6.91 Mrd.
3.23%3.2%16.06x1.29x2.07x6.96x9.52x 7.02 Mrd.
0.24%0.24%33.93x6x3.86x16.44x18.15x 6.55 Mrd.
0.97%1.17%40.78x9.37x7.81x28.97x32.35x 4.43 Mrd.
3.04%3.99%16.69x2.67x2.66x12.41x12.03x 4.13 Mrd.
1.27%1.72%15.45x0.74x2.1x9.06x11.51x 4.05 Mrd.
3.05%3.39%19.74x5.29x6.16x17.51x18.95x 2.74 Mrd.
2.9%2.98%13.64x2.75x3.17x11.82x13.06x 2.71 Mrd.
Durchschnitt 2.07% 2.3% 22.47x 3.57x 3.79x 14.38x 17.00x 11.1 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 1.5% 1.65% 25.55x 3.54x 4.16x 15.80x 19.34x
Generische Pharmazeutika